BioWorld

Sep. 2, 2002

Summer Of Discontent Ending; Industry Aims For Fall Revival

Talk to enough buy-side analysts and industry boosters, and you're likely to come away with a strangely weary feeling. It's a feeling behind which lies suspicion and skepticism, a grave doubt about even the possibility of optimism. (Bioworld Financial Watch) Read More

Money Raised Year To Date

Stock Winners and Losers For The Week

Holiday Notice

Underwriters' Performance On IPOs From Jan. 1, 2002, To July 31, 2002: Full Credit To Lead Underwriter, Ranked By Gross Proceeds*

Underwriters' Performance On IPOs From Jan. 1, 2002, To July 31, 2002: Full Credit To Lead Underwriter, Ranked By After-Market Performance#

Underwriters' Performance On IPOs From Jan. 1, 2002, To July 31, 2002: Full Credit To All Underwriters, Ranked By Gross Proceeds*

Underwriters' Performance On IPOs From Jan. 1, 2002, To July 31, 2002: Full Credit To All Underwriters Ranked By After-Market Performance#

Underwriters' Performance On All Public Offerings From Jan. 1, 2002, To July 31, 2002: Full Credit To Lead Underwriter, Ranked By Gross Proceeds*

Underwriters' Performance On All Public Offerings From Jan. 1, 2002, To July 31, 2002: Full Credit To Lead Underwriter, Ranked By After-Market Performance#

Underwriters' Performance On All Public Offerings Jan. 1- July 31, 2002: Full Credit To All Underwriters, Ranked By Gross Proceeds*

Underwriters' Performance On All Public Offerings Jan. 1 - July 31, 2002: Full Credit To All Underwriters, Ranked By After-Market Performance*#

BioWorld Stock Report For Public Biotechnology Companies

Today's news in brief

BioWorld

BioWorld briefs for June 8, 2026.

ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins

BioWorld

If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...

New York University identifies new analogues of mannose-6-phosphate

BioWorld Science

New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

3D rendering of β2-Adrenergic receptor GPCR protein molecule embedded in lipid bilayer membrane.

Skape Bio unlocks GPCR targets with de novo-designed miniproteins

BioWorld

Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...